Your browser doesn't support javascript.
loading
LATE and potential estrogen-related risk factors collected 30 years earlier: The 90+ Study.
Paganini-Hill, Annlia; Montine, Thomas J; Bukhari, Syed A; Corrada, Maria M; Kawas, Claudia H; Sajjadi, S Ahmad.
Afiliación
  • Paganini-Hill A; Department of Neurology, University of California, Irvine, California, USA.
  • Montine TJ; Department of Pathology, Stanford University, Palo Alto, California, USA.
  • Bukhari SA; Department of Pathology, Stanford University, Palo Alto, California, USA.
  • Corrada MM; Department of Neurology, University of California, Irvine, California, USA.
  • Kawas CH; Department of Epidemiology, University of California, Irvine, California, USA.
  • Sajjadi SA; Department of Neurology, University of California, Irvine, California, USA.
J Neuropathol Exp Neurol ; 82(2): 120-126, 2023 01 20.
Article en En | MEDLINE | ID: mdl-36562637
ABSTRACT
Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) is a recently described neuropathological construct associated with dementia. This study aimed to investigate in an autopsy study, LATE-NC and its associations with potential estrogen-related risk factors collected about 30 years before death. Participants were part of The 90+ Study and had, as part of the Leisure World Cohort Study, provided information on menstrual and reproductive variables and details of use of estrogen replacement therapy (ERT). No menstrual and reproductive variable showed an association with LATE-NC. Use of ERT, especially long-term use (15+ years) and more recent use (within 1 year of completing the questionnaire), was associated with reduced risk. The odds were significantly lower for long-term (0.39, 95% confidence interval [CI] 0.16-0.95) and recent use (0.39, 95% CI 0.16-0.91) compared with no use. In conclusion, we found that women who reported long-term ERT in their 50s and 60s had a significantly reduced odds of harboring LATE-NC when they died in the 10th and 11th decades of their lives. Our study adds to the existing literature reporting seemingly protective effect of peri- and postmenopausal ERT against neurodegenerative dementia.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_alzheimer_other_dementias / 6_mental_health_behavioral_disorders Asunto principal: Enfermedad de Alzheimer Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adolescent / Female / Humans / Middle aged Idioma: En Revista: J Neuropathol Exp Neurol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_alzheimer_other_dementias / 6_mental_health_behavioral_disorders Asunto principal: Enfermedad de Alzheimer Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adolescent / Female / Humans / Middle aged Idioma: En Revista: J Neuropathol Exp Neurol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
...